Immunolocalization of glutaredoxin in the human corpus luteum

• Published in: Molecular human reproduction 1999-10, Vol.5 (10), p.914-919
• Main Authors: García-Pardo, L., Granados, M.D., Gaytán, F., Padilla, C.A., Martínez-Galisteo, E., Morales, C., Sánchez-Criado, J.E., Bárcena, J.A.
• Format: Article
• Language: English
• Subjects: Apoptosis; Biological and medical sciences; Corpus Luteum - cytology; Corpus Luteum - metabolism; corpus luteum regression; Female; Fundamental and applied biological sciences. Psychology; Gene Expression; glutaredoxin; Glutaredoxins; Hormone metabolism and regulation; Humans; Immunohistochemistry; Luteal Cells - cytology; Luteal Cells - metabolism; Luteal Phase - genetics; Luteal Phase - metabolism; luteinization; Luteolysis - genetics; Luteolysis - metabolism; Mammalian female genital system; Oxidative Stress; Oxidoreductases; Pregnancy; Proteins - genetics; Proteins - metabolism; Reactive Oxygen Species - metabolism; redox regulation; Vertebrates: reproduction
• ISSN: 1360-9947; 1460-2407; 1460-2407
• DOI: 10.1093/molehr/5.10.914

Glutaredoxin (Grx) is a small protein with oxidoreductase activity which is involved in the cellular defence against oxidative stress. Corpus luteum (CL) regression has been related to the generation of reactive oxygen species (ROS). We have studied the presence of glutaredoxin in the human ovary during the ovulatory cycle using polyclonal antibodies developed against recombinant human Grx. Immunostaining was only detected between days 15 and 23 of the cycle and was localized exclusively in the corpus luteum. Grx-positive cells corresponded to granulosa-derived luteal cells (GLC) whereas the remaining luteal cell types were not immunostained. In general, Grx immunoreactivity was parallel to the functional activity of the CL. Most GLC were immunostained on days 15–16 of the cycle, whereas on days 17–19 immunoreaction was found mainly at the inner and outer aspects of the granulosa lutein layer (GLL). After this stage only isolated GLC showed Grx immunoreactivity and no reaction was found from day 23 of the cycle onward. In two CL of pregnancy that were also studied, isolated GLC showed Grx immunoreactivity. Loss of Grx immunoreactivity was coincident with the appearance of morphological signs of structural luteolysis, such as shrinkage of the GLL and the presence of apoptotic cells. These data suggest that Grx, as a cellular antioxidant, plays an important role in the mechanisms of human CL development.